Anatomic Pathology Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product and Services, Application, End User, and Geography

Description

List of Tables

According to our new research study on "Anatomic Pathology Market Forecast to 2031 - Global Analysis - by Products and Services, Application, End User, and Geography," the market is anticipated to grow from US$ 30.22 billion in 2023 and is projected to reach US$ 53.27 billion by 2031; it is expected to register a CAGR of 7.3% during 2023-2031. The increase in the prevalence of cancer and kidney diseases and the rise in the number of strategic initiatives are contributing to the anatomic pathology market growth. However, the shortage of skilled professionals and stringent government regulations hamper the market growth. Further, the integration of artificial intelligence and machine learning is expected to bring new anatomic pathology market trends in the coming years.

Anatomical pathology is the study of organs and tissues to determine the causes and effects of particular diseases. Anatomic (or anatomical) pathology is the branch of medicine that studies the effect of disease on the structure of body organs, both as a whole (grossly) and microscopically. The primary role of anatomic pathology is to identify abnormalities that can help to diagnose disease and manage treatment. Although one of the frequent uses of anatomic pathology is to help identify and manage various types of tumors or cancers, it is also valuable in evaluating other conditions, including kidney and liver diseases, autoimmune disorders, and infections, for example.

North America accounted for a major share of the global anatomic pathology market in 2023. The North America anatomic pathology market is segmented into the US, Canada, and Mexico.

In the US, cancer has a significant impact on society. A few common cancer types in the country are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, and liver cancer. As per the National Cancer Institute, in 2021, ~17.43 individuals were living with cancer at any site in the US. The number of cancer survivors is projected to reach 22.2 million by 2030. This mounting prevalence of cancer cases is expected to increase the demand for pathologic diagnostic tests such as biopsies, fine-needle aspiration (FNA), genetic testing, and other novel techniques. Moreover, there has been unprecedented growth in innovative and improved medical technologies in the US in recent years. This growth resulted in the development of advanced medical devices in the healthcare industry. Players operating in the US anatomic pathology market continuously focus on the development of innovative and convenient instruments and consumables for pathological procedures. In November 2023, Illumina Inc., US, a global leader in DNA sequencing and array-based technologies, introduced TruSight Oncology 500 ctDNA v2 (plate number 1 ctDNA v2), a new version of its distributed liquid biopsy assay that allows comprehensive noninvasive genomic profiling of circulating tumor DNA from blood, complementing tissue-based testing. In 2020, F. Hoffmann-La Roche received the US Food and Drug Administration (FDA) approval for the expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer. Thus, factors such as the high prevalence of cancer, strong presence of some major players, and availability of high-quality infrastructure for hospitals and clinical laboratories bolster the growth of the anatomic pathology market in the US.

Governments and private agricultural associations are highly focused on advancements in crop genomics to improve the characteristics of crops. The Agricultural Genome to Phenome Initiative (AG2PI) of the National Institute of Food and Agriculture focuses on collaborative engagements to develop a community of researchers studying both crop and animal genetics, which would lay the foundation for expanding knowledge about genomes and phenomes that are important to the agriculture sector in the US. The initiative is likely to result in the development of approaches to understanding how variable weather, environments, and production systems impact genetic diversity in crops and animals. Thus, the rising number of initiatives taken to foster studies related to the genetic makeup of crops for yield and quality improvement are likely to favor the anatomic pathology market in the US in the future.

Growing Focus on Personalized Medicines to Provide Market Opportunities in Future

Personalized medicines are mainly designed by considering individuals' genetic profiles to guide the decisions made with respect to the prevention, diagnosis, and treatment of a disease. They provide an opportunity for drug manufacturers to develop agents that target patient groups that do not respond to medications as intended or for them who do not respond as expected to traditional healthcare practices. There is much evidence indicating that a substantial portion of the variability in drug response depends on factors that are genetically controlled, including age, nutrition, environmental exposure, and health status. Genomics plays an important role in the emergence of personalized medicines, as having the knowledge of a patient's genetic profile would help doctors in selecting an apt medication. Personalized medicines are helpful in improving healthcare by enabling each patient to receive earlier diagnoses, risk assessments, and optimal treatments.

Pathologists play an important role in developing and implementing molecular and genomic tests in practice. Personalized medicines are used in the treatment of diseases such as breast cancer and cardiovascular diseases. Personalized anticancer medicines exhibit fewer and less severe side effects than other types of treatment as they are designed for more specific action. Further, with the ongoing progress in research and clinical studies, personalized medicines are likely to reach even greater potential to improve the quality of patient care. Thus, the growing focus on personalized medicines is expected to boost the anatomic pathology market growth.

Anatomic Pathology Market: Competitive Landscape and Key Developments

F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, BD, and PHC Holdings Corporation are among the key companies operating in the anatomic pathology market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Organisation for Economic Co-operation and Development are among the primary and secondary sources referred to while preparing the anatomic pathology market report.

Product Code: TIPRE00002999

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Anatomic Pathology Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Anatomic Pathology Market - Key Market Dynamics

5.1 Anatomic Pathology Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increase in Prevalence of Cancer and Kidney Diseases
- 5.2.2 Rise in Number of Strategic Initiatives
5.3 Market Restraints
- 5.3.1 Lack of Skilled Professionals
- 5.3.2 Stringent Government Regulations
5.4 Market Opportunities
- 5.4.1 Growing Focus on Personalized Medicines
5.5 Future Trends
- 5.5.1 Integration of Artificial Intelligence and Machine Learning
5.6 Impact of Drivers and Restraints:

6. Anatomic Pathology Market - Global Market Analysis

6.1 Anatomic Pathology Market Revenue (US$ Million), 2021-2031
6.2 Anatomic Pathology Market Forecast Analysis

7. Anatomic Pathology Market Analysis - by Product and Services

7.1 Services
- 7.1.1 Overview
- 7.1.2 Services: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Consumables
- 7.3.1 Overview
- 7.3.2 Consumables: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

8. Anatomic Pathology Market Analysis - by Application

8.1 Disease Diagnosis
- 8.1.1 Overview
- 8.1.2 Disease Diagnosis: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Drug Discovery and Development
- 8.2.1 Overview
- 8.2.2 Drug Discovery and Development: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

9. Anatomic Pathology Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Research Laboratories: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

10. Anatomic Pathology Market - Geographical Analysis

10.1 Overview
10.2 North America
- 10.2.1 North America Anatomic Pathology Market Overview
- 10.2.2 North America: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2.3 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
- 10.2.4 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
- 10.2.5 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
- 10.2.6 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
- 10.2.7 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
- 10.2.8 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.2.8.1 United States: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.8.1.1 United States: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.2.8.1.1.1 United States: Anatomic Pathology Market Breakdown, by Services
    - 10.2.8.1.1.2 United States: Anatomic Pathology Market Breakdown, by Instruments
    - 10.2.8.1.2 United States: Anatomic Pathology Market Breakdown, by Application
    - 10.2.8.1.3 United States: Anatomic Pathology Market Breakdown, by End User
  - 10.2.8.2 Canada: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.8.2.1 Canada: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.2.8.2.1.1 Canada: Anatomic Pathology Market Breakdown, by Services
    - 10.2.8.2.1.2 Canada: Anatomic Pathology Market Breakdown, by Instruments
    - 10.2.8.2.2 Canada: Anatomic Pathology Market Breakdown, by Application
    - 10.2.8.2.3 Canada: Anatomic Pathology Market Breakdown, by End User
  - 10.2.8.3 Mexico: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.8.3.1 Mexico: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.2.8.3.1.1 Mexico: Anatomic Pathology Market Breakdown, by Services
    - 10.2.8.3.1.2 Mexico: Anatomic Pathology Market Breakdown, by Instruments
    - 10.2.8.3.2 Mexico: Anatomic Pathology Market Breakdown, by Application
    - 10.2.8.3.3 Mexico: Anatomic Pathology Market Breakdown, by End User
10.3 Europe
- 10.3.1 Europe Anatomic Pathology Market Overview
- 10.3.2 Europe: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.3 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
- 10.3.4 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
- 10.3.5 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
- 10.3.6 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
- 10.3.7 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
- 10.3.8 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.3.8.1 United Kingdom: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.8.1.1 United Kingdom: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.3.8.1.1.1 United Kingdom: Anatomic Pathology Market Breakdown, by Services
    - 10.3.8.1.1.2 United Kingdom: Anatomic Pathology Market Breakdown, by Instruments
    - 10.3.8.1.2 United Kingdom: Anatomic Pathology Market Breakdown, by Application
    - 10.3.8.1.3 United Kingdom: Anatomic Pathology Market Breakdown, by End User
  - 10.3.8.2 Germany: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.8.2.1 Germany: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.3.8.2.1.1 Germany: Anatomic Pathology Market Breakdown, by Services
    - 10.3.8.2.1.2 Germany: Anatomic Pathology Market Breakdown, by Instruments
    - 10.3.8.2.2 Germany: Anatomic Pathology Market Breakdown, by Application
    - 10.3.8.2.3 Germany: Anatomic Pathology Market Breakdown, by End User
  - 10.3.8.3 France: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.8.3.1 France: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.3.8.3.1.1 France: Anatomic Pathology Market Breakdown, by Services
    - 10.3.8.3.1.2 rance: Anatomic Pathology Market Breakdown, by Instruments
    - 10.3.8.3.2 France: Anatomic Pathology Market Breakdown, by Application
    - 10.3.8.3.3 France: Anatomic Pathology Market Breakdown, by End User
  - 10.3.8.4 Italy: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.8.4.1 Italy: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.3.8.4.1.1 Italy: Anatomic Pathology Market Breakdown, by Services
    - 10.3.8.4.1.2 Italy: Anatomic Pathology Market Breakdown, by Instruments
    - 10.3.8.4.2 Italy: Anatomic Pathology Market Breakdown, by Application
    - 10.3.8.4.3 Italy: Anatomic Pathology Market Breakdown, by End User
  - 10.3.8.5 Spain: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.8.5.1 Spain: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.3.8.5.1.1 Spain: Anatomic Pathology Market Breakdown, by Services
    - 10.3.8.5.1.2 Spain: Anatomic Pathology Market Breakdown, by Instruments
    - 10.3.8.5.2 Spain: Anatomic Pathology Market Breakdown, by Application
    - 10.3.8.5.3 Spain: Anatomic Pathology Market Breakdown, by End User
  - 10.3.8.6 Rest of Europe: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.8.6.1 Rest of Europe: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.3.8.6.1.1 Rest of Europe: Anatomic Pathology Market Breakdown, by Services
    - 10.3.8.6.1.2 Rest of Europe: Anatomic Pathology Market Breakdown, by Instruments
    - 10.3.8.6.2 Rest of Europe: Anatomic Pathology Market Breakdown, by Application
    - 10.3.8.6.3 Rest of Europe: Anatomic Pathology Market Breakdown, by End User
10.4 Asia Pacific
- 10.4.1 Asia Pacific Anatomic Pathology Market Overview
- 10.4.2 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.3 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
- 10.4.4 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
- 10.4.5 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
- 10.4.6 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
- 10.4.7 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
- 10.4.8 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.4.8.1 China: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.8.1.1 China: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.4.8.1.1.1 China: Anatomic Pathology Market Breakdown, by Services
    - 10.4.8.1.1.2 China: Anatomic Pathology Market Breakdown, by Instruments
    - 10.4.8.1.2 China: Anatomic Pathology Market Breakdown, by Application
    - 10.4.8.1.3 China: Anatomic Pathology Market Breakdown, by End User
  - 10.4.8.2 Japan: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.8.2.1 Japan: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.4.8.2.1.1 Japan: Anatomic Pathology Market Breakdown, by Services
    - 10.4.8.2.1.2 Japan: Anatomic Pathology Market Breakdown, by Instruments
    - 10.4.8.2.2 Japan: Anatomic Pathology Market Breakdown, by Application
    - 10.4.8.2.3 Japan: Anatomic Pathology Market Breakdown, by End User
  - 10.4.8.3 India: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.8.3.1 India: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.4.8.3.1.1 India: Anatomic Pathology Market Breakdown, by Services
    - 10.4.8.3.1.2 India: Anatomic Pathology Market Breakdown, by Instruments
    - 10.4.8.3.2 India: Anatomic Pathology Market Breakdown, by Application
    - 10.4.8.3.3 India: Anatomic Pathology Market Breakdown, by End User
  - 10.4.8.4 Australia: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.8.4.1 Australia: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.4.8.4.1.1 Australia: Anatomic Pathology Market Breakdown, by Services
    - 10.4.8.4.1.2 Australia: Anatomic Pathology Market Breakdown, by Instruments
    - 10.4.8.4.2 Australia: Anatomic Pathology Market Breakdown, by Application
    - 10.4.8.4.3 Australia: Anatomic Pathology Market Breakdown, by End User
  - 10.4.8.5 South Korea: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.8.5.1 South Korea: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.4.8.5.1.1 South Korea: Anatomic Pathology Market Breakdown, by Services
    - 10.4.8.5.1.2 South Korea: Anatomic Pathology Market Breakdown, by Instruments
    - 10.4.8.5.2 South Korea: Anatomic Pathology Market Breakdown, by Application
    - 10.4.8.5.3 South Korea: Anatomic Pathology Market Breakdown, by End User
  - 10.4.8.6 Rest of APAC: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.8.6.1 Rest of APAC: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.4.8.6.1.1 Rest of APAC: Anatomic Pathology Market Breakdown, by Services
    - 10.4.8.6.1.2 Rest of APAC: Anatomic Pathology Market Breakdown, by Instruments
    - 10.4.8.6.2 Rest of APAC: Anatomic Pathology Market Breakdown, by Application
    - 10.4.8.6.3 Rest of APAC: Anatomic Pathology Market Breakdown, by End User
10.5 Middle East and Africa
- 10.5.1 Middle East and Africa Anatomic Pathology Market Overview
- 10.5.2 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.3 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
- 10.5.4 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
- 10.5.5 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
- 10.5.6 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
- 10.5.7 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
- 10.5.8 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.5.8.1 South Africa: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.8.1.1 South Africa: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.5.8.1.1.1 South Africa: Anatomic Pathology Market Breakdown, by Services
    - 10.5.8.1.1.2 South Africa: Anatomic Pathology Market Breakdown, by Instruments
    - 10.5.8.1.2 South Africa: Anatomic Pathology Market Breakdown, by Application
    - 10.5.8.1.3 South Africa: Anatomic Pathology Market Breakdown, by End User
  - 10.5.8.2 Saudi Arabia: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.8.2.1 Saudi Arabia: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.5.8.2.1.1 Saudi Arabia: Anatomic Pathology Market Breakdown, by Services
    - 10.5.8.2.1.2 Saudi Arabia: Anatomic Pathology Market Breakdown, by Instruments
    - 10.5.8.2.2 Saudi Arabia: Anatomic Pathology Market Breakdown, by Application
    - 10.5.8.2.3 Saudi Arabia: Anatomic Pathology Market Breakdown, by End User
  - 10.5.8.3 United Arab Emirates: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.8.3.1 United Arab Emirates: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.5.8.3.1.1 United Arab Emirates: Anatomic Pathology Market Breakdown, by Services
    - 10.5.8.3.1.2 United Arab Emirates: Anatomic Pathology Market Breakdown, by Instruments
    - 10.5.8.3.2 United Arab Emirates: Anatomic Pathology Market Breakdown, by Application
    - 10.5.8.3.3 United Arab Emirates: Anatomic Pathology Market Breakdown, by End User
  - 10.5.8.4 Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.8.4.1 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.5.8.4.1.1 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Services
    - 10.5.8.4.1.2 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Instruments
    - 10.5.8.4.2 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Application
    - 10.5.8.4.3 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by End User
10.6 South and Central America
- 10.6.1 South and Central America Anatomic Pathology Market Overview
- 10.6.2 South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.3 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
- 10.6.4 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
- 10.6.5 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
- 10.6.6 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
- 10.6.7 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
- 10.6.8 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.6.8.1 Brazil: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.8.1.1 Brazil: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.6.8.1.1.1 Brazil: Anatomic Pathology Market Breakdown, by Services
    - 10.6.8.1.1.2 Brazil: Anatomic Pathology Market Breakdown, by Instruments
    - 10.6.8.1.2 Brazil: Anatomic Pathology Market Breakdown, by Application
    - 10.6.8.1.3 Brazil: Anatomic Pathology Market Breakdown, by End User
  - 10.6.8.2 Argentina: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.8.2.1 Argentina: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.6.8.2.1.1 Argentina: Anatomic Pathology Market Breakdown, by Services
    - 10.6.8.2.1.2 Argentina: Anatomic Pathology Market Breakdown, by Instruments
    - 10.6.8.2.2 Argentina: Anatomic Pathology Market Breakdown, by Application
    - 10.6.8.2.3 Argentina: Anatomic Pathology Market Breakdown, by End User
  - 10.6.8.3 Rest of South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.8.3.1 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.6.8.3.1.1 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Services
    - 10.6.8.3.1.2 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Instruments
    - 10.6.8.3.2 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Application
    - 10.6.8.3.3 Rest of South and Central America: Anatomic Pathology Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Anatomic Pathology Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Beckman Coulter Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Hologic Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Agilent Technologies Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 BioGenex Laboratories Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Diapath S.p.A.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bio SB
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Merck KGaA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 PHC Holdings Corporation
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms